Elutia reprices stock options and grants new equity to CEO, CFO, CSO, and other employees

ELUTIA INC.

CEO C. Randal Mills' existing options and RSUs vesting thresholds lowered to $6, $10, $14, $18 per share.
CEO granted 650,000 options and 650,000 RSUs; CFO and CSO each granted 200,000 options and 200,000 RSUs.
Non-executive employee options repriced from >$7 to $3.61 per share, covering 144,427 shares.
New equity grants to other employees include 565,561 options and 1,167,500 RSUs.
Vesting of some awards contingent on FDA clearance of CanGarooRM antibiotic-eluting envelope.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.